SIRT1 and obesity due to melanocortin 4 receptor deficiency: Sirtuins appear to have a complex but generally protective effect against obesity; increasing NAD+ levels or SIRT1 and SIRT6 activity may be a helpful therapeutic strategy for preventing and treating type 2 diabetes, MetS, and insulin resistance.